
|Articles|November 1, 2018 (Updated: November 15, 2020)
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharm Exec's 2019 Pipeline Reportover 7 years ago
High-Risk Marketing Violations Draw Scrutinyover 7 years ago
Biopharma Business Checkover 7 years ago
Patent Protection for Cannabis?over 7 years ago
Steadying the Path of Good Scienceover 7 years ago
Southeast Biotech: Rising Tall in the Valleyover 7 years ago
Fighting for a Streamlined European HTA Schemeover 7 years ago
Stunted Innovation in Drug Development?over 7 years ago
Country Report: AlgeriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5




